In bodybuilding, joint stiffness can occur due to intense training and the use of anabolic-androgenic steroids (AAS). AAS use may lead to joint discomfort by altering fluid retention and collagen synthesis, resulting in restricted movement and pain. This can affect performance, recovery, and overall joint health, while also facilitating the occurrence of injuries. Therefore, one […]Read More
Bolasterone is an oral AAS that was developed in the 1960s by the pharmaceutical company Wyeth. It was initially used in the treatment of cachexia, a condition characterized by severe weight loss and muscle wasting in patients with advanced cancer or other chronic illnesses. Unfortunately, it was abandoned because it was too powerful to be […]Read More
Post-Finasteride Syndrome (PFS) is a term used to describe a set of persistent side effects that some individuals experience after discontinuing the use of Finasteride. Finasteride is a prescription drug used to treat hair loss and an enlarged prostate in men. It works by inhibiting the conversion of Testosterone to Dihydrotestosterone (DHT), the main hormone […]Read More
Dimethazine (also known as DMZ, Dostalone or Mebolazine) is a 17-alpha-alkylated (oral) AAS derived from DHT that is essentially a dimer of Superdrol, meaning that it’s chemical structure is TWO Superdrol molecules bound by an “azine” ringe, something that only one other AAS has (Bolazine, which is 2x Masteron molecules bound together). One of the […]Read More
© 2024 Steroidify. All rights reserved. Privacy Policy. Contact Us.
